Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000501927 | SCV000595763 | uncertain significance | not specified | 2016-03-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002376924 | SCV002625187 | uncertain significance | Inborn genetic diseases | 2022-07-12 | criteria provided, single submitter | clinical testing | The c.3981A>T (p.L1327F) alteration is located in exon 30 (coding exon 30) of the MED23 gene. This alteration results from a A to T substitution at nucleotide position 3981, causing the leucine (L) at amino acid position 1327 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002490837 | SCV002779292 | uncertain significance | Intellectual disability, autosomal recessive 18 | 2022-04-12 | criteria provided, single submitter | clinical testing |